RaySearch Laboratories AB (publ)
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RSLBF research report →
Companywww.raysearchlabs.com
RaySearch Laboratories AB (publ), a medical technology company, develops software solutions for cancer treatment worldwide. It develops and markets RayStation, a treatment planning system for treatment activities, such as automated planning, adaptive therapy, multi-criteria optimization, fast and accurate dose computations, OAR dose reduction, robustness, machine learning, VMAT, IMRT, 3D-CRT, virtual simulation, electron beam therapy, tomotherapy, stereotactic, proton therapy, carbon ion therapy, and boron neutron capture therapy. The company also develops RayPlan, a treatment planning system for supporting a range of treatment planning activities for 3D-CRT, IMRT, VMAT, tomotherapy, and electron beam radiation therapy; and RayCare, an oncology information system to support cancer treatment activities.
- CEO
- Johan Lof
- IPO
- 2015
- Employees
- 416
- HQ
- Stockholm, SE
Price Chart
Valuation
- Market Cap
- $844.21M
- P/E
- 31.17
- P/S
- 5.36
- P/B
- 6.70
- EV/EBITDA
- 16.29
- Div Yield
- 1.96%
Profitability
- Gross Margin
- 81.36%
- Op Margin
- 21.58%
- Net Margin
- 17.21%
- ROE
- 23.62%
- ROIC
- 14.35%
Growth & Income
- Revenue
- $1.34B · 12.77%
- Net Income
- $227.80M · 11.93%
- EPS
- $6.65 · 11.95%
- Op Income
- $292.30M
- FCF YoY
- -40.64%
Performance & Tape
- 52W High
- $37.36
- 52W Low
- $19.57
- 50D MA
- $25.46
- 200D MA
- $28.72
- Beta
- 0.93
- Avg Volume
- 14
Get TickerSpark's AI analysis on RSLBF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our RSLBF Coverage
We haven't published any research on RSLBF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate RSLBF Report →